04:12 PM EDT, 06/05/2024 (MT Newswires) -- Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer, on June 03, 2024, sold 2,175 shares in Vertex Pharmaceuticals ( VRTX ) for $1,000,500. Following the Form 4 filing with the SEC, Tatsis has control over a total of 49,098 shares of the company, with 49,098 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/875320/000087532024000168/xslF345X03/wk-form4_1717618128.xml

Price: 482.00, Change: -1.04, Percent Change: -0.22